Last $5.87 USD
Change Today +0.29 / 5.20%
Volume 112.2K
BOTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 4:30 PM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

biota pharmaceuticals inc (BOTA) Key Developments

Biota Pharmaceuticals, Inc. Presents at 26th Annual ROTH Conference, Mar-11-2014 12:30 PM

Biota Pharmaceuticals, Inc. Presents at 26th Annual ROTH Conference, Mar-11-2014 12:30 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States. Speakers: Russell H. Plumb, Chief Executive Officer, President, Principal Financial Officer and Director.

Biota Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2013

Biota Pharmaceuticals, Inc. reported earnings results for the second quarter and six months ended December 31, 2013. For the quarter, the company has posted net loss of $100,000, or $0 per share, compared to a net income of $4.6 million, or $0.16 per share, for the same quarter ended December 31, 2012. Total revenue was $18.5 million, compared to $10.4 million for the same quarter ended December 31, 2012. Net loss for the six months ended December 31, 2013 was $4 million, or $0.14 loss per share, compared to a net loss of $2.6 million, or $0.09 loss per share, for the same period ended December 31, 2012. Total revenue for the six months ended December 31, 2013 was $30.8 million, compared to $11.8 million for the same period ended December 31, 2012.

Biota Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Month Periods Ended December 31, 2013

Biota Pharmaceuticals, Inc. announced unaudited consolidated earnings results for the second quarter and six month periods ended December 31, 2013. For the quarter, the company reported total revenue of $18.5 million against $10.4 million a year ago. Loss from operations was $0.1 million against $7.8 million a year ago. Loss before tax was $0.1 million against income before tax of $4.6 million a year ago. Net loss was $0.1 million or $0.00 per diluted share against net income of $4.6 million $0.16 per diluted share a year ago. For the six months, the company reported total revenue of $30.8 million against $11.8 million a year ago. Loss from operations was $4.2 million against $15.7 million a year ago. Loss before tax was $4.1 million against income before tax of $2.7 million a year ago. Net loss was $4.0 million or $0.14 per diluted share against $2.6 million $0.09 per diluted share a year ago.

Biota Pharmaceuticals, Inc., Q2 2014 Earnings Call, Feb 10, 2014

Biota Pharmaceuticals, Inc., Q2 2014 Earnings Call, Feb 10, 2014

Biota Pharmaceuticals, Inc. to Report Q2, 2014 Results on Feb 10, 2014

Biota Pharmaceuticals, Inc. announced that they will report Q2, 2014 results on Feb 10, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BOTA:US $5.87 USD +0.29

BOTA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Roche Holding AG SFr.255.20 CHF -1.00
View Industry Companies
 

Industry Analysis

BOTA

Industry Average

Valuation BOTA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.0x
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.